Jeffrey B. Sperry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jeffrey B. Sperry has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Connor Barrett
Vertex Pharmaceuticals, 50 Northern Avenue, Boston, Massachusetts 02210, United States
3 shared publicationsAntonio C. Ferretti
Chemical Process Development, Bristol Myers Squibb, 1 Squibb Dr, New Brunswick, New Jersey 08903, United States
2 shared publications- Ayman D. Allian
Synthetic Molecule Design & Development
2 shared publications - Han Xia
Synthetic Molecule Design and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, United States
2 shared publications Michael Azuma
Vertex Pharmaceuticals Incorporated, Process Chemistry, 50 Northern Avenue, Boston, Massachusetts 02210, United States
2 shared publications- Shane Stone
Vertex Pharmaceuticals Incorporated, Process Chemistry, 50 Northern Avenue, Boston, Massachusetts 02210, United States
2 shared publications
Latest Publications
- 24 February 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (3) , 674-682
Energetics, Shock Sensitivity, and Thermal Hazards of Cubane and Bicyclo[1.1.1]pentane Derivatives
- 24 February 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (3) , 674-682
Energetics, Shock Sensitivity, and Thermal Hazards of Cubane and Bicyclo[1.1.1]pentane Derivatives
- 29 March 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (4) , 1083-1088
Development of a Safe and Scalable Method to Prepare 3-Bromo-N-alkyl-1,6-naphthyridones via Enamine Cyclization
- 29 March 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (4) , 1083-1088
Development of a Safe and Scalable Method to Prepare 3-Bromo-N-alkyl-1,6-naphthyridones via Enamine Cyclization
- 22 February 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (3) , 704-718
Process Safety in the Pharmaceutical Industry─Part II: Process Safety Labs and Instruments Used in Process Safety Labs for Thermal Hazards
- 22 February 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (3) , 704-718
Process Safety in the Pharmaceutical Industry─Part II: Process Safety Labs and Instruments Used in Process Safety Labs for Thermal Hazards
- 23 August 2021
- Published by American Chemical Society (ACS) in ACS Chemical Health & Safety
- Vol. 28 (5) , 297-302
Precompetitive Collaborations in the Pharmaceutical Industry: Process Safety Groups Work Together to Reduce Hazards, from R&D Laboratories to Manufacturing Facilities
Process Safety scientists in the pharmaceutical industry are tasked with keeping the laboratories, manufacturing facilities, people, and environment safe from thermal runaway reactions. This group of highly trained chemists and engineers has forged an alliance stretching across company lines to help ensure the safety of the global pharmaceutical manufacturing sector. In this Commentary, we share our challenges, strategies, and opportunities for working together to ensure the safety of our respective companies and external vendors. We discuss our three platforms for collaborating and sharing ideas to help communicate the importance of pharmaceutical companies cooperating in a precompetitive space for the greater good.
- 23 August 2021
- Published by American Chemical Society (ACS) in ACS Chemical Health & Safety
- Vol. 28 (5) , 297-302
Precompetitive Collaborations in the Pharmaceutical Industry: Process Safety Groups Work Together to Reduce Hazards, from R&D Laboratories to Manufacturing Facilities
Process Safety scientists in the pharmaceutical industry are tasked with keeping the laboratories, manufacturing facilities, people, and environment safe from thermal runaway reactions. This group of highly trained chemists and engineers has forged an alliance stretching across company lines to help ensure the safety of the global pharmaceutical manufacturing sector. In this Commentary, we share our challenges, strategies, and opportunities for working together to ensure the safety of our respective companies and external vendors. We discuss our three platforms for collaborating and sharing ideas to help communicate the importance of pharmaceutical companies cooperating in a precompetitive space for the greater good.
- 8 July 2021
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 25 (7) , 1690-1700
Importance of Thermal Stability Data to Avoid Dangerous Reagents: Temozolomide Case Study
- 8 July 2021
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 25 (7) , 1690-1700
Importance of Thermal Stability Data to Avoid Dangerous Reagents: Temozolomide Case Study
- 24 October 2020
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 24 (11) , 2529-2548
Process Safety in the Pharmaceutical Industry—Part I: Thermal and Reaction Hazard Evaluation Processes and Techniques
Process safety groups in the pharmaceutical industry are important components of active pharmaceutical ingredient (API) development through its life cycle from discovery to commercial scale. The pharmaceutical process safety laboratory staff conduct a series of tests to identify chemically unstable reagents, intermediates and solvents, and mixtures to ensure that the proposed operating conditions provide a sufficient safety margin from the onset of undesired and potentially catastrophic thermal decomposition. Across several pharmaceutical companies, the methods used for these assessments and how results and conclusions are made are widespread (vide infra). A working group was created with members from several pharmaceutical companies within the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ), with the goal of precompetitive collaboration and to understand each of the participating companies’ procedures and assessment regarding process safety. Each company was invited to provide input using a blind survey format. This was done in the interest of making this knowledge accessible for the participating companies and the wider community of other pharma and chemical companies and even academic institutions in the US and throughout the world. This article provides the results of this in-depth survey of the members of the IQ Consortium thermal hazard working group. General issues around different tools used to assess thermal hazard risk and questions regarding staffing and tech transfer of process safety data/information from development to manufacturing were addressed. A snapshot of how various assessment strategies are employed as a function of stage of development (early, mid, and late) is also presented.
- 24 October 2020
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 24 (11) , 2529-2548
Process Safety in the Pharmaceutical Industry—Part I: Thermal and Reaction Hazard Evaluation Processes and Techniques
Process safety groups in the pharmaceutical industry are important components of active pharmaceutical ingredient (API) development through its life cycle from discovery to commercial scale. The pharmaceutical process safety laboratory staff conduct a series of tests to identify chemically unstable reagents, intermediates and solvents, and mixtures to ensure that the proposed operating conditions provide a sufficient safety margin from the onset of undesired and potentially catastrophic thermal decomposition. Across several pharmaceutical companies, the methods used for these assessments and how results and conclusions are made are widespread (vide infra). A working group was created with members from several pharmaceutical companies within the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ), with the goal of precompetitive collaboration and to understand each of the participating companies’ procedures and assessment regarding process safety. Each company was invited to provide input using a blind survey format. This was done in the interest of making this knowledge accessible for the participating companies and the wider community of other pharma and chemical companies and even academic institutions in the US and throughout the world. This article provides the results of this in-depth survey of the members of the IQ Consortium thermal hazard working group. General issues around different tools used to assess thermal hazard risk and questions regarding staffing and tech transfer of process safety data/information from development to manufacturing were addressed. A snapshot of how various assessment strategies are employed as a function of stage of development (early, mid, and late) is also presented.
- Open Access
- 16 June 2020
- Published by American Chemical Society (ACS) in ACS Chemical Health & Safety
- Vol. 27 (4) , 229-234
Near Miss Involving Red Phosphorus
A recent near miss involving ignition of a small amount of red phosphorus was investigated. The near miss is discussed in detail along with the root cause investigation. Six possible root causes were examined. Three were deemed unlikely, and three were either probable or likely root causes. In the end, electrostatic discharge appears to be the most likely root cause. The Case Study serves to remind scientists about the importance of keeping a clutter-free work area and about hazards associated with common reagents.
- 16 June 2020
- Published by American Chemical Society (ACS) in ACS Chemical Health & Safety
- Vol. 27 (4) , 229-234
Open AccessNear Miss Involving Red Phosphorus
A recent near miss involving ignition of a small amount of red phosphorus was investigated. The near miss is discussed in detail along with the root cause investigation. Six possible root causes were examined. Three were deemed unlikely, and three were either probable or likely root causes. In the end, electrostatic discharge appears to be the most likely root cause. The Case Study serves to remind scientists about the importance of keeping a clutter-free work area and about hazards associated with common reagents.
- Top Cited Papers
- 30 July 2018
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 22 (9) , 1262-1275
Thermal Stability Assessment of Peptide Coupling Reagents Commonly Used in Pharmaceutical Manufacturing
- 30 July 2018
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 22 (9) , 1262-1275
Top Cited PapersThermal Stability Assessment of Peptide Coupling Reagents Commonly Used in Pharmaceutical Manufacturing
- 7 November 2012
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 16 (11) , 1854-1860
A Robust Process for an mGluR5 Negative Allosteric Modulator: Difluoromethylation and Sonogashira Coupling on Large Scale
- 7 November 2012
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 16 (11) , 1854-1860
A Robust Process for an mGluR5 Negative Allosteric Modulator: Difluoromethylation and Sonogashira Coupling on Large Scale